Interleukin-1β with learning and memory

被引:63
|
作者
Huang, Zhen-Bo [1 ]
Sheng, Guo-Qing [1 ]
机构
[1] Chinese Acad Sci, CAS Key Lab Regenerat Biol, S China Inst Stem Cell & Regenerat Med, Guangzhou Inst Biomed & Hlth, Guangzhou 510530, Guangdong, Peoples R China
基金
中国国家自然科学基金;
关键词
interleukin-1; beta; learning; memory; dose; age; memory type; memory stage; LONG-TERM POTENTIATION; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; ALZHEIMERS-DISEASE; AGED MICE; LEGIONELLA-PNEUMOPHILA; BRAIN INTERLEUKIN-1; RECEPTOR ANTAGONIST; WORKING-MEMORY; MESSENGER-RNA; IMMUNE-SYSTEM;
D O I
10.1007/s12264-010-6023-5
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Interleukin-1 beta ( IL-1 beta) is one of the first cytokines ever described. It has long been recognized to play an important role in mediating inflammation and orchestrating the physiological and behavioral adjustments that occur during sickness. Recently, accumulating evidence has indicated that IL-1 beta also adversely affects cognitive function. Nevertheless, there are also some reports showing no effects or even beneficial effects of IL-1 beta on learning and memory. The relationship between IL-1 beta and cognitive impairment has not been clearly elucidated. Here we reviewed the evidence of both negative and positive effects of IL-1 beta on learning and memory, and the key factors that may affect the effects of IL-1 beta on learning and memory were discussed.
引用
收藏
页码:455 / 468
页数:14
相关论文
共 50 条
  • [41] NUCLEAR INTERNALIZATION AND DNA-BINDING ACTIVITIES OF INTERLEUKIN-1, INTERLEUKIN-1 RECEPTOR AND INTERLEUKIN-1 RECEPTOR COMPLEXES
    WEITZMANN, MN
    SAVAGE, N
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 187 (02) : 1166 - 1171
  • [42] INTERLEUKIN-1 RECEPTOR ANTAGONIST COMPETITIVELY INHIBITS THE BINDING OF INTERLEUKIN-1 TO THE TYPE-II INTERLEUKIN-1 RECEPTOR
    GRANOWITZ, EV
    MANCILLA, J
    CLARK, BD
    DINARELLO, CA
    CLINICAL RESEARCH, 1991, 39 (02): : A462 - A462
  • [43] Interleukin-1 receptor accessory protein is required for interleukin-1 signalling
    Martin, M
    Wesche, H
    Resch, K
    Lang, D
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1997, 355 (04) : 302 - 302
  • [44] The interleukin-1 and interleukin-1 converting enzyme families in the cardiovascular system
    Loppnow, H
    Werdan, K
    Reuter, G
    Flad, HD
    EUROPEAN CYTOKINE NETWORK, 1998, 9 (04) : 675 - 680
  • [45] INTERLEUKIN-1 RECEPTOR ANTAGONIST - A NEW MEMBER OF THE INTERLEUKIN-1 FAMILY
    AREND, WP
    JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (05): : 1445 - 1451
  • [46] INTERLEUKIN-1 RECEPTOR ANTAGONIST ACTIVITY OF A HUMAN INTERLEUKIN-1 INHIBITOR
    HANNUM, CH
    WILCOX, CJ
    AREND, WP
    JOSLIN, FG
    DRIPPS, DJ
    HEIMDAL, PL
    ARMES, LG
    SOMMER, A
    EISENBERG, SP
    THOMPSON, RC
    NATURE, 1990, 343 (6256) : 336 - 340
  • [47] Release of Interleukin-1α or Interleukin-1β Depends on Mechanism of Cell Death
    England, Hazel
    Summersgill, Holly R.
    Edye, Michelle E.
    Rothwell, Nancy J.
    Brough, David
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (23) : 15942 - 15950
  • [48] Induction of interleukin-1α production in murine Sertoli cells by interleukin-1
    Zeyse, D
    Lunenfeld, E
    Beck, M
    Prinsloo, I
    Huleihel, M
    BIOLOGY OF REPRODUCTION, 2000, 62 (05) : 1291 - 1296
  • [49] INTERLEUKIN-1 RECEPTOR ANTAGONIST - EFFECTIVENESS AGAINST INTERLEUKIN-1 FEVER
    COCEANI, F
    LEES, J
    REDFORD, J
    BISHAI, I
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1992, 70 (12) : 1590 - 1596
  • [50] Interleukin-1 and interleukin-1 receptor antagonist in systemic lupus erythematosus
    Chang, DM
    IMMUNOLOGICAL INVESTIGATIONS, 1997, 26 (5-7) : 649 - 659